![](/img/cover-not-exists.png)
Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS
Tural, Deniz, Batur, Sebnem, Erdamar, Sibel, Akar, Emre, Kepil, Nuray, Mandel, Nil Molinas, Serdengeçti, SüheylaVolume:
35
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-013-1138-8
Date:
February, 2014
File:
PDF, 467 KB
english, 2014